Gapping up
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- MU +16.7%, GES +11.6% (also declares special dividend of $2.25/sh), CAAP +4.6%, CMC +4.4%, LAAC +2%, KBH +0.9%
Other news:
- ARGX +13.1% (Chugai reports results of Phase III study of enspryng in patients with generalized myasthenia gravis)
- WDC +7.2% (in sympathy with strong MU earnings)
- INDI +5.4% (makes strategic investment in AI processor company)
- CLVT +4.1% (acquires AI start up to accelerate strategy and business development success for life sciences & healthcare clients)
- BNOX +3.7% (Results of the Full Dataset Analysis from ATTUNE Phase 2b Trial of BNC210 in Patients with Post-Traumatic Stress Disorder)
- STX +3.6% (in sympathy with strong MU earnings)
- ARBE +2.6% (opens an office in Shanghai)
- HRTG +2.3% (authorizes new $10 mln share repurchase program)
- COHR +2.2% (introduces 100G ZR QSFP28 optics transceiver)
- SNPS +1.9% (approves sale process its Software Integrity business; also updates FY24 guidance)
- GTLB +1.6% (acquires Oxeye)
Analyst comments:
- AVGO +2.9% (upgraded to Outperform from Market Perform at TD Cowen)
- BRZE +2.8% (upgraded to Buy from Neutral at UBS)
- NOW +2.1% (initiated with an Overweight at KeyBanc Capital Markets)
- LYG +2% (upgraded to Buy from Neutral at BofA Securities)
- DHT +1.7% (upgraded to Buy from Hold at Jefferies)
- MSFT +0.9% (initiated with an Overweight at KeyBanc Capital Markets)